thyroid carcinoma

You have access
¹²⁴I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer
Walter Jentzen, Femke Verschure, Annelie van Zon, Rudie van de Kolk, Roel Wierts, Jochen Schmitz, Andreas Bockisch and Ina Binse

Journal of Nuclear Medicine October 1, 2016, 57 (10) 1499-1504; DOI: https://doi.org/10.2967/jnumed.115.170571
You have access
Dose–Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of ¹²⁴I PET/CT
Roel Wierts, Boudewijn Brans, Bas Havekes, Gerrit J. Kemerink, Servais G. Halders, Nicolaas N. Schaper, Walter H. Backes, Felix M. Mottaghy and Walter Jentzen

Journal of Nuclear Medicine July 1, 2016, 57 (7) 1027-1032; DOI: https://doi.org/10.2967/jnumed.115.168799
You have access
Assessment of Simplified Blood Dose Protocols for the Estimation of the Maximum Tolerable Activity in Thyroid Cancer Patients Undergoing Radioiodine Therapy Using ¹²⁴I
Walter Jentzen, Andreas Bockisch and Marcus Ruhlmann

Journal of Nuclear Medicine June 1, 2015, 56 (6) 832-838; DOI: https://doi.org/10.2967/jnumed.114.153031
You have access
Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using ¹²⁴I PET Imaging
Walter Jentzen, Jan Hoppenbrouwers, Paul van Leeuwen, Daan van der Velden, Rudie van de Kolk, Thorsten Dirk Poeppel, James Nagarajah, Wolfgang Brandau, Andreas Bockisch and Sandra Rosenbaum-Krumme

Journal of Nuclear Medicine November 1, 2014, 55 (11) 1759-1765; DOI: https://doi.org/10.2967/jnumed.114.144089

Main menu

User menu

Search

thyroid carcinoma